Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35263519

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2022 Mar 10
First author
Hortobagyi GN

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cell Rep Med. 2022 Jun 21;3(6):100664. doi: 10.1016/j.xcrm.2022.100664.
    note
    Source null
    related pmid
    35732146
    relationship
    Comment in

Authors and identifiers

  1. name
    Hortobagyi GN
    type
    Author
  2. name
    Stemmer SM
    type
    Author
  3. name
    Burris HA
    type
    Author
  4. name
    Yap YS
    type
    Author
  5. name
    Sonke GS
    type
    Author
  6. name
    Hart L
    type
    Author
  7. name
    Campone M
    type
    Author
  8. name
    Petrakova K
    type
    Author
  9. name
    Winer EP
    type
    Author
  10. name
    Janni W
    type
    Author
  11. name
    Conte P
    type
    Author
  12. name
    Cameron DA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hortobagyi GN
    type
    Author
  2. name
    Stemmer SM
    type
    Author
  3. name
    Burris HA
    type
    Author
  4. name
    Yap YS
    type
    Author
  5. name
    Sonke GS
    type
    Author
  6. name
    Hart L
    type
    Author
  7. name
    Campone M
    type
    Author
  8. name
    Petrakova K
    type
    Author
  9. name
    Winer EP
    type
    Author
  10. name
    Janni W
    type
    Author
  11. name
    Conte P
    type
    Author
  12. name
    Cameron DA
    type
    Author
bibliography ids
  1. nci-bib-793335461c5cb784748635cf
book metadata
content sha256
98511adc0da2d5cb90467145f500e1f39a27bed14eaaf94bca6915886509e815
document type
citation
dois
  1. 10.1056/NEJMoa2114663
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:35263519
immutable id
pubmed:35263519@98511adc0da2d5cb90467145f500e1f39a27bed14eaaf94bca6915886509e815
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
10
name
The New England journal of medicine
nlm unique id
0255562
pages
942-950
volume
386
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cell Rep Med. 2022 Jun 21;3(6):100664. doi: 10.1016/j.xcrm.2022.100664.
    note
    Source null
    related pmid
    35732146
    relationship
    Comment in
outcomes validated
false
pmid
35263519
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
173a4d4d84ddd203598e2788854c99d8f78e2ee33771ee00448956ccd0d7a121
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2022 Mar 10
precision
day
year
2022
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35263519/
title
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.

Preserved source evidence · Not medical advice